Colinz Labs

Colinz_Labs03 May 2024

Pharmaceuticals

₹

+3.92 (+9.33%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Colinz Labs

Colinz Labs

Pharmaceuticals

Colinz_Labs03 May 2024

₹

+3.92 (+9.33%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
04-May-2024	BC	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Notice pf Board Meeting Pursuant Regul	29-May-2024
10-Jan-2024	BC	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve Intimation for the Board Meeting under	31-Jan-2024
14-Oct-2023	BC	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Notice of Board Meeting pursuant to Re	31-Oct-2023
31-Jul-2023	BC	The outcome of the meeting held on 31-07-2023 for approving the unaudited Quarterly Results for the quarter ended 30-06-2023. and other related matter as mentioned in outcome of the meeting. Pleas	29-Sep-2023
31-Jul-2023	BC	Annual General Meeting	22-Sep-2023

No Rights has been declared by Colinz_Labs

Book Closure

Record Date	Split Date	Purpose
29-May-2024	-	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Notice pf Board Meeting Pursuant Regul
31-Jan-2024	-	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve Intimation for the Board Meeting under
31-Oct-2023	-	COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Notice of Board Meeting pursuant to Re
29-Sep-2023	-	The outcome of the meeting held on 31-07-2023 for approving the unaudited Quarterly Results for the quarter ended 30-06-2023. and other related matter as mentioned in outcome of the meeting. Pleas
22-Sep-2023	01 Jan'1900	Annual General Meeting

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Colinz Laboratories Ltd ₹45.92(+3.92/9.33%)	45.92	+3.92	20.99	12.33	43.73	1.98
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	1.71	1.79	1.90	1.72	1.68	1.92
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1.71	1.79	1.90	1.72	1.68	1.92
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.05	0.08	0.04	0.04	0.04	0.05
Total Income	1.76	1.86	1.94	1.76	1.72	1.96
Total Expenditure	1.57	1.66	1.75	1.56	1.54	1.75
PBIDT	0.19	0.20	0.19	0.20	0.18	0.21
Interest	0.01	0.01	0.01	0.01	0.01	0.01
PBDT	0.18	0.19	0.19	0.19	0.16	0.20
Depreciation	0.03	0.03	0.03	0.03	0.03	0.03
Tax	0.04	0.04	0.03	0.03	0.03	0.05
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.11	0.12	0.12	0.13	0.10	0.12
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.11	0.12	0.12	0.13	0.10	0.12

EPS (Unit Curr.)	0.42	0.49	0.48	0.51	0.41	0.46
EPS (Adj) (Unit Curr.)	0.42	0.49	0.48	0.51	0.41	0.46
Calculated EPS (Unit Curr.)	0.42	0.49	0.48	0.51	0.29	0.33
Calculated EPS (Adj) (Unit Curr.)	0.42	0.49	0.48	0.51	0.29	0.33
Calculated EPS (Ann.) (Unit Curr.)	1.69	1.96	1.92	2.03	1.16	1.32
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.69	1.96	1.92	2.03	1.16	1.32
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	2.52	2.52	2.52	2.52	3.55	3.55
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	11.11	11.17	10.00	11.63	10.71	10.94
PBDTM(%)	10.53	10.61	10.00	11.05	9.52	10.42
PATM(%)	6.43	6.70	6.32	7.56	5.95	6.25

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	2.52	3.55	3.55	3.54	3.54	3.54
Reserves Total	5.62	4.14	3.75	3.29	3.30	3.21
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	8.14	7.69	7.30	6.83	6.84	6.75
Secured Loans	0.00	0.00	0.00	0.38	0.68	0.42
Unsecured Loans	0.27	0.48	0.99	0.00	0.00	0.00
Total Debt	0.27	0.48	0.99	0.38	0.68	0.42
Total Liabilities	8.41	8.17	8.29	7.21	7.52	7.17
APPLICATION OF FUNDS :
Gross Block	6.17	6.91	6.88	6.72	6.67	6.66
Less : Accumulated Depreciation	4.46	5.05	4.85	4.66	4.46	4.25
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1.71	1.86	2.03	2.06	2.21	2.41
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.66	0.67	0.61	0.36	0.50	0.53
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.94	0.93	1.25	1.69	1.90	1.97
Sundry Debtors	1.13	1.21	1.30	1.49	1.68	1.68
Cash and Bank	5.73	5.21	4.68	2.60	1.99	1.87
Loans and Advances	0.03	0.04	0.05	0.06	0.07	0.03
Total Current Assets	7.84	7.38	7.27	5.84	5.64	5.55
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1.52	1.37	1.46	1.11	0.99	1.58
Provisions	0.09	0.13	0.13	0.12	0.12	0.12
Total Current Liabilities	1.61	1.50	1.59	1.23	1.11	1.70
Net Current Assets	6.23	5.88	5.69	4.61	4.53	3.85
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.21	0.22	0.23	0.26	0.29	0.32
Net Deferred Tax	-0.21	-0.22	-0.23	-0.26	-0.29	-0.32
Total Assets	8.39	8.19	8.10	6.77	6.95	6.47
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	5.21	4.68	2.61	1.99	1.87
Net Cash from Operating Activities	0.40	0.47	2.16	0.58	0.12
Net Cash Used In Investing Activities	0.01	-0.03	-0.16	-0.04	-0.01
Net Cash Used In Financing Activities	0.11	0.09	0.08	0.06	0.02
Net Inc./Dec In Cash And Cash Equivalents	0.52	0.52	2.07	0.60	0.12
Cash And Cash Equivalents At End Of The Year	5.73	5.21	4.68	2.60	1.99

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

66.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

34.00%

**Promoter pledged shareholding 66.00%

About Colinz Laboratories Ltd

Colinz Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 20.99 crores. It has reported a sales of Rs. 1.71 crores and a net profit of Rs. 0.11 crores for the quarter ended December 2018. The company management includes , L S Mani,N K Menon,Vasant K Bhat,A Krishna Kumar (Colinz Laboratories Ltd) among others.

Chairman

Registered office

A-101 Pratik Industrial Estate,Mulund Goregaon Link Road,Mumbai,Maharashtra,400078

FAX :

Background

Incorporation Year1986

Face Value₹10

Market Lot1

How to buy Colinz Labs shares on nse?

To buy Colinz Labs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Colinz Labs share price today?

The Colinz Labs shares price on nse is Rs.45.92 today.

What is the market cap of Colinz Labs shares on BSE ?

The company has a market capitalization of Rs.20.99Cr

What is the PE & PB ratio of Colinz Labs shares ?

PE is 43.73 and PB is 1.98

What is the 52 Week High and Low of Colinz Labs shares?

Colinz Labs stock price high: Rs.46.9 Colinz Labs stock price low: Rs.33.35